Skip to main content

Table 3 WAY-169916 gene-profiling experiment with spleen from rat adjuvant arthritis model

From: The utility of pathway selective estrogen receptor ligands that inhibit nuclear factor-κB transcriptional activity in models of rheumatoid arthritis

 

Av. control

Av. CFA

Av. CFA + WAY-169916

AFC CFA

AFC WAY-169916

Inhibition by WAY-169916 (%)

Transcription factors

      

   CCAAT/enhancer binding protein (C/EBP), beta

16.8

39.8

19.6

2.37

0.49

87.6

   NF-E2-related factor 2

14.2

30.3

19.6

2.13

0.65

66.2

Immune mediators

      

   Mast cell protease 2

5.3

11.8

5.9

2.20

0.50

91.4

   Arachidonate 5-lipoxygenase-activating protein

18.9

46.5

23.9

2.46

0.51

82.0

   Chemokine-like factor 1

10.5

28.9

18.9

2.75

0.65

54.3

   Phospholipase A2, group IIA

33.8

71.7

60.3

2.12

0.84

30.0

   Proteoglycan 2, bone marrow

27.6

147.4

59.1

5.34

0.40

73.7

Immune related

      

   CD14 antigen

15.9

32.3

19.1

2.04

0.59

80.2

   Peptidoglycan recognition protein

10.2

39.6

14.5

3.88

0.37

85.2

   Lipopolysaccharide-binding protein

3.3

10.2

4.4

3.10

0.43

83.6

   IL-1 receptor, type II

2.2

8.1

3.5

3.71

0.44

76.8

   Defensin RatNP-3 precursor

31.7

105.3

63.5

3.32

0.60

56.8

   Suppressor of cytokine signalling 3

15.2

35.3

15.2

2.33

0.43

99.7

   Complement component 3

13.3

28.4

24.2

2.14

0.85

27.6

   Defensin NP-2 precursor

58.9

166.6

102.8

2.83

0.62

59.3

   Defensin NP-4 precursor

54.1

164.9

104.7

3.05

0.64

54.3

   Paired immunoglobulin-like receptor-B

11.0

22.7

18.3

2.07

0.81

37.6

   25 oligoadenylate synthetase

24.6

51.4

24.8

2.09

0.48

99.2

   Tumor necrosis factor receptor II

7.3

15.8

8.9

2.18

0.56

81.0

   S100 calcium-binding protein A8 (calgranulin A)

52.2

184.5

91.5

3.54

0.50

70.3

   S100 calcium-binding protein A9 (calgranulin B)

144.9

382.7

242.1

2.64

0.63

59.1

   Ficolin B

42.3

121.1

74.7

2.86

0.62

58.9

   Myelin and lymphocyte protein

11.8

27.6

19.9

2.34

0.72

49.1

Protease

      

   Matrix metalloproteinase 9

2.0

8.4

3.5

4.24

0.42

75.8

   Chymase 1

2.9

9.2

5.1

3.16

0.56

64.8

Transport

      

   Monocarboxylate transporter

10.3

24.4

10.0

2.38

0.41

102.3

   Lipocalin 2

16.3

55.3

33.0

3.39

0.60

57.1

Acute phase

      

   Haptoglobin

10.5

37.5

12.9

3.58

0.34

90.9

Metabolism

      

   Uridine phosphorylase I

8.9

32.8

9.1

3.68

0.28

99.3

   Guanine deaminase

17.8

39.5

20.7

2.21

0.52

86.9

   Microsomal glutathione S-transferase 1

40.0

87.6

51.2

2.19

0.58

76.6

   GTP cyclohydrolase 1

11.6

25.5

23.6

2.20

0.93

13.8

   Hepatic steroid hydroxylase II A2

9.0

18.7

21.5

2.07

1.15

-29.0

Adhesion

      

   C-CAM4 protein

11.5

24.5

16.0

2.12

0.65

65.6

   Fibronectin 1

57.2

116.6

91.3

2.04

0.78

42.6

Unknown function

      

   Expressed sequence tag

20.0

41.5

25.1

2.08

0.61

76.1

  1. AFC, average fold change; Av., average; CFA, complete Freund's adjuvant.